PMA device
Technolas 217A Excimer Laser System
Technolas Perfect Vision GmbH · Excimer Laser System (LZS, Class III) · First FDA decision Dec 22, 2000, newest Feb 25, 2003Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
0
Naming "Technolas 217A"
MAUDE reports
0
Brand "Technolas 217A", since 2015
PubMed studies
5
Mentioning "Technolas 217A"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Technolas 217A Excimer Laser System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- TECHNOLAS 217A EXCIMER LASER SYSTEMPMA supplement
P990027-S004 · Decided Feb 25, 2003 · 438 days after receipt · Panel Track
Device type: Excimer laser system (LZS) · Ophthalmology
- TECHNOLAS 217A EXCIMER LASER SYSTEMPMA supplement
P990027-S005 · Decided Mar 13, 2002 · 41 days after receipt · Normal 180 Day Track
Device type: Excimer laser system (LZS) · Ophthalmology
- TECHNOLAS 217A EXCIMER LASER SYSTEMPMA supplement
P990027-S002 · Decided May 17, 2002 · 539 days after receipt · Panel Track
Device type: Excimer laser system (LZS) · Ophthalmology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Technolas 217A", any status and sponsor, newest update first.
No registered device study names "Technolas 217A".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Technolas 217A", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LZS
7,603 reports: 949 malfunction, 6,624 injury, 12 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Technolas 217A"[tiab]. The summary above synthesizes these.
- Nomogram considerations with the Technolas 217A for treatment of myopia.
Anderson NJ, Hardten DR, Davis EA, et al. · J Refract Surg · 2003Research Support, Non-U.S. Gov't
- Randomized prospective clinical study comparing induced aberrations with IntraLase and Hansatome flap creation in fellow eyes: potential impact on wavefront-guided laser in situ keratomileusis.
Tran DB, Sarayba MA, Bor Z, et al. · J Cataract Refract Surg · 2005Clinical Trial, Comparative Study
- Outcomes of laser in situ keratomileusis in a Refractive Surgery fellowship program.
Bowers PJ, Zeldes SS, Price MO, et al. · J Refract Surg · 2004Comparative Study
- Novel objective method for comparing ablation centration with and without pupil tracking following myopic laser in situ keratomileusis using the bausch & lomb technolas 217A.
Qazi MA, Pepose JS, Sanderson JP, et al. · Cornea · 2009Research Support, Non-U.S. Gov't
- A prospective randomized clinical trial of laser in situ keratomileusis with two different lasers.
Twa MD, Lembach RG, Bullimore MA, et al. · Am J Ophthalmol · 2005Clinical Trial, Comparative Study
Other devices of this type
Also filed under product code LZS.
- WaveLight EX500 LaserAlcon Laboratories, Inc. · PMA 2025
- Wavelight Allegretto Wave Excimer Laser SystemAlcon Laboratories, Inc. · PMA 2013
- STAR S4 IR Excimer Laser System and iDESIGN Refractive StudioAmo Manufacturing USA, LLC · PMA 2019
- Nidek EC-5000 Excimer Laser SystemNidek Co., Ltd. · PMA 2018
- Bausch & Lomb Technolas T217Z Zyoptix Laser SystemTechnolas Perfect Vision GmbH · PMA 2010
- Ladarvision 4000 Excimer Laser System and the Ladar 6000 Excimer Laser SystemAlcon Laboratories · PMA 2006
- Allegretto Wave Eye-Q Excimer Laser SystemAlcon Laboratories, Inc. · PMA 2015
- iDESIGN Refractive Studio, STAR S4 IR Excimer Laser SystemAmo Manufacturing USA, LLC · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.